Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BIO Calls For Journal Publication Of COVID-19 Trial Data, Independent FDA

Sep 04 2020

• By Brenda Sandburg

Reading email document text file online on computer laptop or send electronic digital mail letter content on pc vector flat cartoon illustration, concept of newsletter correspondence modern design — BIO's open letter to industry sets principles for conducting and reviewing COVID-19 clinical trial data • Source: Shutterstock

Related Content

COVID-19 Vaccine Advisory Committee May Help Determine US FDA Approach To Licensure

Aug 28 2020

FDA Sidelines Chief Spokesperson As It Grapples With Fallout From COVID-19 Plasma Authorization

Aug 30 2020

Coronavirus Notebook: Fauci Calls For Restraint In Disclosing Early Data; Bipartisan Lawmakers Want Warp Speed Audit

Aug 05 2020

Plasma Authorization Raises Fears Of Politically-Influenced COVID-19 Vaccine Decisions, Compromised FDA

Aug 25 2020

COVID Vaccine Distribution Plan From National Academies Leaves Room For Adjustments Based On Trial Results

Sep 02 2020

Moderna’s COVID-19 Vaccine Spurs Immune Response In All Phase I Subjects At All Doses

Jul 15 2020

CanSino Claims Lead In COVID-19 Vaccine Race And Takes Swipe At Moderna’s Ethics

Jun 26 2020

Coronavirus Update: Moderna Progesses To Phase II, Russia Approves Homegrown Antiviral

Jun 01 2020

Related Companies

Moderna, Inc.

Novavax, Inc.

GSK plc

Merck & Co., Inc.

Pfizer Inc.

Johnson & Johnson

CanSino Biologics Inc.

Additional Topics

United States Coronavirus COVID-19 Vaccines Clinical Trials Drug Approval Standards FDA Policy BioPharmaceutical

More from Vaccines

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.